ING GROEP NV: THC position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ING GROEP NV on THC, newest first. How the timeline and the estimate are built.
ING GROEP NV held 28,600 THC shares at 2026-06-30 per its 13F-HR filed 2026-08-13.
the latest 13F is the newest step
- period ended2026-06-3013F 28,600 sharesChange vs previous 13F +28,600 shares
0.03% of the 13F portfolio, value $5,350,488.
13F-HR 0001140361-26-032761 filed by ING GROEP NV
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 0 sharesChange vs previous 13F -13,300 shares
13F-HR 0001140361-26-004715 filed by ING GROEP NV
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2025-09-3013F 13,300 sharesChange vs previous 13F -24,400 shares
0.01% of the 13F portfolio, value $2,700,432.
13F-HR 0001140361-25-040700 filed by ING GROEP NV
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 37,700 sharesChange vs previous 13F +37,700 shares
0.04% of the 13F portfolio, value $6,635,200.
13F-HR 0001140361-25-029070 filed by ING GROEP NV
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 0 sharesChange vs previous 13F -120,000 shares
13F-HR 0001140361-25-002810 filed by ING GROEP NV
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2024-09-3013F 120,000 sharesChange vs previous 13F not available
0.12% of the 13F portfolio, value $19,944,000.
13F-HR 0001140361-24-045362 filed by ING GROEP NV
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).